Lovastatin recalls

The FDA has published 4 recalls involving Lovastatin since 2014. The latest was reported on 14 Aug 2019. Most were for potency & assay. American Health Packaging has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 14 Aug 2019

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 50%Class III 2 50%

Why lovastatin is recalled

Potency & Assay375%
Labeling Errors125%

Companies

By year

2019250%
2018125%
2014125%

All lovastatin recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
14 Aug 2019Drug	CLASS III	Lovastatin Tablets USP, 40 mg recalled by American Health PackagingLovastatin	American Health Packaging	Potency & Assay	Nationwide
27 Feb 2019Drug	CLASS III	Lovastatin Tablets USP, 40 mg recalled by Lupin PharmaceuticalsLovastatin	Lupin Pharmaceuticals	Potency & Assay	Nationwide
24 Jan 2018Drug	CLASS II	Lovastatin Tablets USP, 40 mg Unit Dose recalled by AVKARE	Avkare	Potency & Assay	Nationwide
29 Jan 2014Drug	CLASS II	Lovastatin, Tablet, 20 mg recalled by Aidapak Services	Aidapak Services	Labeling Errors	4 states

Should you stop taking Lovastatin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.